GGrantIndex
Sort

130,381 grants matching hiv

PRIDEnet for the All of Us Research Program

$996,370
Mitchell Ryan Lunn · Stanford University · OT2 · FY2019 · OD

Malaria immunology

$996,334
Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Teixobactin Development for Tuberculosis

$996,278
Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2023 · AI

Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies

$996,252
Milen Kirilov · Ingenious Targeting Laboratory, Inc. · R44 · FY2024 · AI

AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans

$996,178
Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2018 · HG

Individual, Network and Spatial Drivers of HIV and HCV among PWID in India

$996,173
Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2020 · DA

Subclinical Vascular Disease and Metabolic Abnormalities in MACS

$996,118
Wendy S Post · Johns Hopkins University · R01 · FY2011 · HL

Analytical Resources Core

$996,049
Nathan A Vandergrift · Duke University · P01 · FY2016 · AI

Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates

$996,038
Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2020 · AI

Anti-HIV Therapeutics that Target HIV Nuclear Import

$995,849
International Therapeutics, Inc. · R44 · FY2001 · AI

Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.

$995,831
Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Point-of-Care Rapid RNA test for HIV

$995,819
Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2019 · AI

Opiate drug abuse and CNS vulnerability to HIV

$995,804
Kurt Francis Hauser · Virginia Commonwealth University · P01 · FY2008 · DA

HORMONAL CONTRACEPTION & RISK OF HIV ACQUISITION

$995,731
Morrison Charles · · N01 · FY2007 · HD

HORMONAL CONTRACEPTION & RISK OF HIV ACQUISITION

$995,731
· N01 · FY2007 · HD

Regeneration of Epidermal Nerves in Human Diabetic Neuropathy

$995,582
Angela Hansen · Winsantor, Inc. · R44 · FY2020 · DK

Naloxone Nasal Spray Development

$995,554
Daniel Paul Wermeling · Antiop, Inc. · R42 · FY2014 · DA

Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies

$995,450
Milen Kirilov · Ingenious Targeting Laboratory, Inc. · R44 · FY2023 · AI

Community-Based VCT Tanzania

$995,445
Michael D Sweat · Medical University Of South Carolina · U01 · FY2010 · MH

Pilot Proteomics Center on Drug Abuse HIV/AIDS

$995,400
Ruth Hogue Angeletti · Albert Einstein College Of Medicine · P20 · FY2009 · DA

The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS

$995,284
Patrick J Loehrer · Indiana University Indianapolis · U54 · FY2020 · CA

An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users

$995,241
Sherry Deren · New York University · P30 · FY2010 · DA

Structural study of the HIV1 gp41 coat protein

$995,227
Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Structural study of the HIV1 gp41 coat protein

$995,227
Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Structural study of the HIV1 gp41 coat protein

$995,227
Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK